Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell transplantation.
Olivieri A, Lucesole M, Capelli D, Gini G, Montanari M, Candela M, Troiani E, Scortechini I, Poloni A, Leoni P. Olivieri A, et al. Among authors: troiani e. Biol Blood Marrow Transplant. 2005 Aug;11(8):627-36. doi: 10.1016/j.bbmt.2005.05.002. Biol Blood Marrow Transplant. 2005. PMID: 16041313 Free article.
Mobilization-driven postconsolidation therapy in elderly patients with acute myeloid leukemia: feasibility and efficacy of autologous stem cell transplantation versus low-dose gemtuzumab ozogamicin.
Capelli D, Chiarucci M, Poloni A, Saraceni F, Mancini G, Trappolini S, Troiani E, Montanari M, Scortechini I, Offidani M, Rupoli S, Scortechini AR, Gini G, Discepoli G, Leoni P, Olivieri A. Capelli D, et al. Among authors: troiani e. Biol Blood Marrow Transplant. 2014 Sep;20(9):1399-406. doi: 10.1016/j.bbmt.2014.05.019. Epub 2014 May 28. Biol Blood Marrow Transplant. 2014. PMID: 24880020 Free article. Clinical Trial.
Modified BEAM as conditioning regimen for lymphoma patients undergoing autologous hematopoietic stem cell transplantation.
Galieni P, Troiani E, Bigazzi C, Mazzotta S, Ruggieri M, Pezzoni V, Dalsass A, Mestichelli F, Caraffa P, Travaglini F, Ferretti S, Angelini M, Angelini S, Falcioni S. Galieni P, et al. Among authors: troiani e. Bone Marrow Transplant. 2018 Jan;53(1):91-93. doi: 10.1038/bmt.2017.206. Epub 2017 Oct 2. Bone Marrow Transplant. 2018. PMID: 28967898 No abstract available.
6q deletion detected by fluorescence in situ hybridization using bacterial artificial chromosome in chronic lymphocytic leukemia.
Dalsass A, Mestichelli F, Ruggieri M, Gaspari P, Pezzoni V, Vagnoni D, Angelini M, Angelini S, Bigazzi C, Falcioni S, Troiani E, Alesiani F, Catarini M, Attolico I, Scortechini I, Discepoli G, Galieni P. Dalsass A, et al. Among authors: troiani e. Eur J Haematol. 2013 Jul;91(1):10-9. doi: 10.1111/ejh.12115. Epub 2013 May 24. Eur J Haematol. 2013. PMID: 23560441
The detection of circulating plasma cells may improve the Revised International Staging System (R-ISS) risk stratification of patients with newly diagnosed multiple myeloma.
Galieni P, Travaglini F, Vagnoni D, Ruggieri M, Caraffa P, Bigazzi C, Falcioni S, Picardi P, Mazzotta S, Troiani E, Dalsass A, Mestichelli F, Angelini M, Camaioni E, Maravalle D, Angelini S, Pezzoni V. Galieni P, et al. Among authors: troiani e. Br J Haematol. 2021 May;193(3):542-550. doi: 10.1111/bjh.17118. Epub 2021 Apr 1. Br J Haematol. 2021. PMID: 33792026 Clinical Trial.
Circulating plasma cells in newly diagnosed symptomatic multiple myeloma as a possible prognostic marker for patients with standard-risk cytogenetics.
Vagnoni D, Travaglini F, Pezzoni V, Ruggieri M, Bigazzi C, Dalsass A, Mestichelli F, Troiani E, Falcioni S, Mazzotta S, Natale A, Angelini M, Ferretti S, Angelini S, Galieni P. Vagnoni D, et al. Among authors: troiani e. Br J Haematol. 2015 Aug;170(4):523-31. doi: 10.1111/bjh.13484. Epub 2015 May 26. Br J Haematol. 2015. PMID: 26010293 Free article.
Unmutated IGHV at diagnosis in patients with early stage CLL independently predicts for shorter follow-up time to first treatment (TTFT).
Galieni P, Troiani E, Picardi P, Angelini M, Mestichelli F, Dalsass A, Maravalle D, Camaioni E, Bigazzi C, Caraffa P, Ruggieri M, Mazzotta S, Mattioli S, Angelini S. Galieni P, et al. Among authors: troiani e. Leuk Res. 2024 Aug;143:107541. doi: 10.1016/j.leukres.2024.107541. Epub 2024 Jun 13. Leuk Res. 2024. PMID: 38905908
Comparative Analysis of Antimicrobial Antibodies between Mild and Severe COVID-19.
Qiu J, Engelbrektson A, Song L, Park J, Murugan V, Williams S, Chung Y, Pompa-Mera EN, Sandoval-Ramirez JL, Mata-Marin JA, Gaytan-Martinez J, Troiani E, Sanguinetti M, Roncada P, Urbani A, Moretti G, Torres J, LaBaer J. Qiu J, et al. Among authors: troiani e. Microbiol Spectr. 2023 Aug 17;11(4):e0469022. doi: 10.1128/spectrum.04690-22. Epub 2023 Jun 6. Microbiol Spectr. 2023. PMID: 37278651 Free PMC article.
28 results